HEPATITIS Australia says it is working to gain information from governments over the potential impact of the global hepatitis B vaccine shortage (PD 6 Apr).
Supplier GSK said it was a "precautionary halt" but it was rebuilding manufacturing capacity.
Meanwhile the EngerixB paediatric dose and Twinrix combined hepatitis A and B vaccine are still available, GSK said.
The above article was sent to subscribers in Pharmacy Daily's issue from 18 Apr 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Apr 17